Immunovant, Inc.: Chief Legal Officer Van Tuyl Christopher sold 1,327 shares

What happened

• Van Tuyl Christopher, chief legal officer, sold 1,327 shares on Oct 7, 2026, reported as a sale (code S) at a weighted average price of $32.06 for total proceeds of $42,544.
• The filing states the sale was to satisfy tax withholding obligations in connection with the vesting and settlement of previously granted RSUs.

Key details

• Transaction date and price: Oct 7, 2026; weighted average price $32.06; individual sale prices ranged from $31.58 - $32.30 per share.
• Shares owned after the transaction: not reported in the Form 4.
• Relevant footnotes:
  • F1: On Apr 1, 2025 the holder was granted 50,787 restricted stock units; 3,174 of those RSUs vested on Oct 1, 2026. The sale represents shares sold to cover tax withholding mandated by the issuer's election to require a "sell to cover" transaction and is not a discretionary transaction by the reporting person.
  • F2: The reported price is a weighted average; the reporting person will provide, upon request, the number of shares sold at each separate price within the stated range.
• Filing date: filed Oct 9, 2026; the Form 4 does not indicate that it was filed late.

Why it may matter

• The filing says the shares were sold to satisfy tax withholding related to RSU vesting (a sell-to-cover), not as a voluntary open-market sale.
• A filing does not show why the insider traded or why the company acted.